GE HealthCare Technologies (GEHC) Net Income towards Common Stockholders (2022 - 2026)
GE HealthCare Technologies' (GEHC) quarterly Net Income towards Common Stockholders came in at $574.0 million in Q2 2026, up 14.8% on a YoY basis from $500.0 million in Q2 2025, and up 39.66% quarter-over-quarter from $411.0 million in Q1 2026.
Analysis
GE HealthCare Technologies (GEHC) Net Income towards Common Stockholders (2022 - 2026) Analysis & Trends
GE HealthCare Technologies (GEHC) has reported Net Income towards Common Stockholders for 5 consecutive years, with $574.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Income towards Common Stockholders rose 14.8% year-over-year to $574.0 million; the trailing twelve-month figure through Jun 2026 stood at $2.1 billion (down 10.0% YoY), and the FY2025 full-year result was $2.1 billion, up 4.57% from the prior year.
- Net Income towards Common Stockholders grew to $574.0 million in Q2 2026 per GEHC's latest filing, from $411.0 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $721.0 million in Q4 2024 and bottomed at $189.0 million in Q1 2023.
- Historically, Net Income towards Common Stockholders has averaged $468.4 million across 5 years, with a median of $467.0 million in 2024.
- The sharpest annual moves came in 2023 and 2024: Net Income towards Common Stockholders plunged 51.41% in 2023, then jumped 97.88% in 2024.
- Over 5 years, Net Income towards Common Stockholders stood at $554.0 million in 2022, then decreased by 27.26% to $403.0 million in 2023, then soared by 78.91% to $721.0 million in 2024, then dropped by 16.5% to $602.0 million in 2025, then declined by 4.65% to $574.0 million in 2026.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $574.0 million, $411.0 million, and $602.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 29.85 Bn | 27.74 Bn | 2.18 Bn | 574.00 Mn |
| 2 | Lantheus Holdings | 6.57 Bn | 5.98 Bn | 241.86 Mn | 75.03 Mn |
| 3 | Heartflow | 4.11 Bn | 3.74 Bn | 53.19 Mn | -15.74 Mn |
| 4 | Neogen | 2.59 Bn | 2.40 Bn | 107.80 Mn | -10.50 Mn |
| 5 | Butterfly Network | 1.99 Bn | 1.87 Bn | 23.29 Mn | -12.91 Mn |
| 6 | Ceribell | 924.56 Mn | 795.30 Mn | 25.94 Mn | -19.27 Mn |
| 7 | QuidelOrtho | 874.92 Mn | 751.52 Mn | - | - |
| 8 | Varex Imaging | 779.06 Mn | 679.86 Mn | 76.70 Mn | 15.90 Mn |
| 9 | Prenetics Global | 340.90 Mn | 281.85 Mn | 30.20 Mn | -8.90 Mn |
| 10 | CapsoVision | 324.09 Mn | 315.02 Mn | 1.87 Mn | -7.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 574.00 Mn |
| Mar 31, 2026 | 411.00 Mn |
| Dec 31, 2025 | 602.00 Mn |
| Sep 30, 2025 | 464.00 Mn |
| Jun 30, 2025 | 500.00 Mn |
| Mar 31, 2025 | 588.00 Mn |
| Dec 31, 2024 | 721.00 Mn |
| Sep 30, 2024 | 470.00 Mn |
| Jun 30, 2024 | 428.00 Mn |
| Mar 31, 2024 | 374.00 Mn |
| Dec 31, 2023 | 403.00 Mn |
| Sep 30, 2023 | 375.00 Mn |
| Jun 30, 2023 | 418.00 Mn |
| Mar 31, 2023 | 189.00 Mn |
| Dec 31, 2022 | 554.00 Mn |
| Sep 30, 2022 | 487.00 Mn |
| Jun 30, 2022 | 485.00 Mn |
| Mar 31, 2022 | 389.00 Mn |